KIG
TNDM icon

Kessler Investment Group’s Tandem Diabetes Care TNDM Stock Holding History

Kessler Investment Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,890
Closed -$122K – 126
2020
Q1 		$122K Sell
1,890
-575
-23% -$40.3K 0.16% 41
2019
Q4 		$147K Buy
2,465
+150
+6% +$9.25K 0.15% 42
2019
Q3 		$137K Sell
2,315
-656
-22% -$41.9K 0.15% 45
2019
Q2 		$192K Sell
2,971
-600
-17% -$38.7K 0.2% 52
2019
Q1 		$227K Buy
3,571
+3,496
+4,661% +$184K 0.23% 54
2018
Q4 		$3K Hold
75
– – ﹤0.01% 93
2018
Q3 		$3K Buy
+75
New +$2.62K ﹤0.01% 132

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kessler Investment Group's TNDM Position: Q2 2020 in Review

Kessler Investment Group sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 1,890 shares — an estimated $122K sold.

Kessler Investment Group first reported a position in TNDM in Q3 2018 and held it in 7 quarters. The position peaked at $227K in Q1 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Kessler Investment Group reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Kessler Investment Group sold 1,890 Tandem Diabetes Care shares in Q2 2020, an estimated $122K.
  • Kessler Investment Group first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 7 quarters.
  • Kessler Investment Group's Tandem Diabetes Care position peaked at $227K in Q1 2019.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Kessler Investment Group's 13F filing for Q2 2020, filed 21 Jul 2020.